Transaction · 0001140361-25-001662

Venker Eric

Venker Eric, PRES, COO, reported an open-market or private sale at Roivant Sciences Ltd. involving 100000.000000 shares for an estimated $1128000.00. Reported holdings after the transaction were 732294.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES, COO
ROIVRoivant Sciences Ltd.
Filing timeJan 23
Trade dateJan 21, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

ROIV price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ROIV since 2025-01-23Filed 588 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001140361-25-001662
Common Shares
Transaction date
Jan 21, 2025
Filed Jan 23, 2025, 02:04 AM · 2d delay
Shares
100k sh
$1.12k per share
Estimated value
-$112M
Computed from shares × price
Holdings after
732k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Sale 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President & COO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlemen…

  2. F2

    The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Com…

  3. F3

    Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencem…

Original filing · 0001140361-25-001662
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ROIV